Medical Cannabis Market Forecast to 2026


Posted August 31, 2018 by jitendra

ccording to the U.S., marijuana was the most widely used drug globally in 2014 with around 183 million users.

 
According to the U.S., marijuana was the most widely used drug globally in 2014 with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse disorders.

Request for Sample Copy of Research Report@

https://www.coherentmarketinsights.com/insight/request-sample/40

Market Dynamics

According to the Medical Marijuana, Inc., an estimated size of the legal marijuana industry in the U.S. was US$ 7.1 billion in 2016 with increase of 25% Y-o-Y. In 2016, 28 states in the U.S. have legalized marijuana for medicinal purpose with some more gearing up for votes on the recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November 2016, voted to legalize the recreational use of marijuana. The accelerated pace of legalization of cannabis (marijuana) in the U.S. has attracted the attention of global investors in the medical cannabis market.

Market Taxonomy

This report segments the global medicinal cannabis on the basis of point of sale, active ingredient and therapeutic application. On the basis of point of sale, the global medical cannabis market is classified into dispensaries, online pharmacy, and hospital pharmacy. Active ingredients of medicinal cannabis include tetrahydrocannabinol (THC) and Cannabidiol (CBD). Therapeutic Application categorized into pain, arthritis, neurological disease, and other applications.

Key features of the study:

This report provides in-depth analysis of medicinal cannabis in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global medicinal cannabis for medical sector market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc and Medical Marijuana Inc.

Detailed Segmentation:

Global Medical Cannabis Market, By Point of Sale:

Dispensaries

Online Pharmacy

Hospital Pharmacy

Global Medical Cannabis Market, By Active Ingredient:

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Global Medical Cannabis Market, By Therapeutic Application:

Pain

Arthritis

Neurological Disease

Epilepsy

Multiple Sclerosis

Other Neurological Applications

Other Applications

Global Medical Cannabis Market, By Geography:

North America

By Country:

U.S.

Request for Discount Before Buying This Business Reports@

https://www.coherentmarketinsights.com/insight/request-discount/40

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1–206–701–6702

Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By jitu
Country United States
Categories Health
Last Updated August 31, 2018